Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Fusen Pharmaceutical Co., Ltd. ( (HK:1652) ).
Fusen Pharmaceutical Company Limited, a pharmaceutical company incorporated in the Cayman Islands, announced that all proposed resolutions at its Annual General Meeting held on May 29, 2025, were passed unanimously by shareholders. These resolutions included the adoption of financial statements, re-election of directors, re-appointment of auditors, and granting of mandates to the board for share issuance and repurchase. The successful passing of these resolutions reflects strong shareholder support and positions the company for continued operational stability and strategic flexibility.
More about Fusen Pharmaceutical Co., Ltd.
Average Trading Volume: 396,447
Technical Sentiment Signal: Sell
Current Market Cap: HK$297.8M
For a thorough assessment of 1652 stock, go to TipRanks’ Stock Analysis page.